Invention Grant
US07262215B2 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors 失效
N-半胱氨酸单取代的吲哚卡巴唑作为蛋白激酶抑制剂

N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors
Abstract:
This invention relates to N-carbacycle monosubstituted indolocarbazole compounds. Furthermore, this invention relates to medicaments comprising N-carbacycle monosubstituted indolocarbazoles compounds and the use of such compounds for treating non-insulin dependent diabetes mellitus, acute stroke and other neurotraumatic injuries, for treating diabetes mellitus, as a chemotherapeutic for the treatment of various malignant diseases, for treating diseases caused by malfunctioning of specific signaling pathways, and for treating neurodegenerative diseases such as for example Alzheimer's disease.
Information query
Patent Agency Ranking
0/0